Bluejay Diagnostics Inc (BJDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,077 | 5,100 | 6,782 | 10,115 | 13,289 |
| TOTAL | $6,528 | $6,582 | $8,902 | $11,789 | $13,936 |
| Non-Current Assets | |||||
| PPE Net | 1,322 | 1,464 | 1,520 | 1,232 | 1,238 |
| Other Non-Current Assets | 397 | 432 | 467 | 501 | 531 |
| TOTAL | $1,719 | $1,896 | $1,987 | $1,733 | $1,769 |
| Total Assets | $8,247 | $8,478 | $10,889 | $13,521 | $15,706 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 756 | 272 | 388 | 636 | 443 |
| Accrued Expenses | 1,876 | 1,392 | 863 | 836 | 1,080 |
| TOTAL | $2,800 | $1,833 | $1,420 | $1,640 | $1,523 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 233 | 269 | 305 | 340 | 372 |
| TOTAL | $233 | $269 | $305 | $340 | $372 |
| Total Liabilities | $3,034 | $2,102 | $1,725 | $1,980 | $1,895 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1 | 1 | 1 | 1 | 1 |
| Common Shares | 0 | 0 | 2 | 0 | 2 |
| Retained earnings | -24,648 | -22,350 | -19,537 | -16,997 | -14,611 |
| TOTAL | $5,213 | $6,376 | $9,163 | $11,541 | $13,811 |
| Total Liabilities And Equity | $8,247 | $8,478 | $10,888 | $13,521 | $15,706 |